Client News
Roquefort Therapeutics PLC – Results of AGMRoquefort Therapeutics (LSE:ROQ, OTCQB: ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market, is pleased to announce that at the Company’s Annual General Meeting (“AGM”) held earlier today, all resolutions proposed were duly passed.
The resolutions were put to shareholders via a poll, the results of which were as follows:
|
Resolution |
Poll Results |
Total Votes Withheld* |
|||
|
For |
Against |
Total Votes Cast |
|||
|
1 |
Shares |
21,890,925 |
– |
21,890,925 |
– |
|
% |
100.00% |
– |
|||
|
2 |
Shares |
21,890,885 |
20 |
21,890,905 |
20 |
|
% |
100.00% |
0.00% |
|||
|
3 |
Shares |
21,890,885 |
20 |
21,890,905 |
20 |
|
% |
100.00% |
0.00% |
|||
|
4 |
Shares |
10,257,712 |
2,713 |
10,260,425 |
11,630,500 |
|
% |
99.97% |
0.03% |
|||
|
5 |
Shares |
21,890,925 |
– |
21,890,925 |
– |
|
% |
100.00% |
– |
|||
|
6 |
Shares |
21,890,885 |
20 |
21,890,905 |
20 |
|
% |
100.00% |
0.00% |
|||
|
7 |
Shares |
21,890,925 |
– |
21,890,925 |
– |
|
% |
100.00% |
– |
|||
|
8 |
Shares |
21,890,905 |
20 |
21,890,925 |
– |
|
% |
100.00% |
0.00% |
|||
|
9 |
Shares |
21,885,885 |
20 |
21,885,905 |
5,020 |
|
% |
100.00% |
0.00% |
|||
|
10 |
Shares |
21,855,276 |
35,629 |
21,890,905 |
20 |
|
% |
99.84% |
0.16% |
|||
|
11 |
Shares |
21,885,071 |
573 |
21,885,644 |
5,281 |
|
% |
100.00% |
0.00% |
|||
* Votes withheld are not counted in the calculation of the proportion of votes for and against a resolution.
Results of AGM – 10:05:01 29 Jun 2023 – ROQ News article | London Stock Exchange
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
CLIENT AREA
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.